Replies to post #20164 on Relief Therapeutics Holding AG (RLFTF)

[trademax42]

Both NeruroRX and Relief sites state phase II/III trials:

"NeuroRx and Relief Therapeutics Announce Data Monitoring Committee Determination to Continue Phase 2/3 Trial of RLF-100 for Critical COVID-19"

https://www.neurorxpharma.com/press-releases/press-release-phase2-3covid-19/

"Phase IIb/III studies in Acute Respiratory Distress Syndrome induced by COVID-19"

https://relieftherapeutics.com/clinical-trials-2/

This provides info on phase II and phase III trials. Might help.

https://www.nccn.org/patients/resources/clinical_trials/phases.aspx

Certainly the current RLF-100 trials have two groups, treatment group and control group.

$RLFTF

Just my opinion of course, do your own dd.

[ratna1]

This trial seem s to have disappeared:
https://clinicaltrials.gov/ct2/show/NCT04311697...note

p.s.:
So have any of you come across any research discussing the usage and impact of VASCEPA for thrombosis and/or pulmonary embolism?

I would appreciate any insights regarding these applications!